ID: ALA459260

Max Phase: Preclinical

Molecular Formula: C28H24O16

Molecular Weight: 616.48

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O[C@H]1[C@H](Oc2c(-c3ccc(O)c(O)c3)oc3cc(O)cc(O)c3c2=O)O[C@H](CO)[C@@H](O)[C@@H]1O)c1cc(O)c(O)c(O)c1

Standard InChI:  InChI=1S/C28H24O16/c29-8-18-21(37)23(39)26(43-27(40)10-4-15(34)20(36)16(35)5-10)28(42-18)44-25-22(38)19-14(33)6-11(30)7-17(19)41-24(25)9-1-2-12(31)13(32)3-9/h1-7,18,21,23,26,28-37,39H,8H2/t18-,21-,23+,26-,28+/m1/s1

Standard InChI Key:  PXGWEUQZDRUMRE-KQOASZHBSA-N

Associated Targets(Human)

Epoxide hydratase 3844 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Angiotensin-converting enzyme 1080 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Xanthine dehydrogenase 2296 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

RAW264.7 28094 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 616.48Molecular Weight (Monoisotopic): 616.1064AlogP: 0.44#Rotatable Bonds: 6
Polar Surface Area: 277.27Molecular Species: ACIDHBA: 16HBD: 10
#RO5 Violations: 3HBA (Lipinski): 16HBD (Lipinski): 10#RO5 Violations (Lipinski): 3
CX Acidic pKa: 6.36CX Basic pKa: CX LogP: 1.44CX LogD: 0.21
Aromatic Rings: 4Heavy Atoms: 44QED Weighted: 0.10Np Likeness Score: 1.94

References

1. Hayashi T, Sawa K, Kawasaki M, Arisawa M, Shimizu M, Morita N..  (1988)  Inhibition of cow's milk xanthine oxidase by flavonoids.,  51  (2): [PMID:3379415] [10.1021/np50056a030]
2. Calis I, Kuruüzüm A, Demirezer LO, Sticher O, Ganci W, Rüedi P..  (1999)  Phenylvaleric acid and flavonoid glycosides from Polygonum salicifolium.,  62  (8): [PMID:10479312] [10.1021/np9900674]
3. Kameda K, Takaku T, Okuda H, Kimura Y, Okuda T, Hatano T, Agata I, Arichi S..  (1987)  Inhibitory effects of various flavonoids isolated from leaves of persimmon on angiotensin-converting enzyme activity.,  50  (4): [PMID:3430165] [10.1021/np50052a017]
4. Luyen BT, Tai BH, Thao NP, Eun KJ, Cha JY, Xin MJ, Lee YM, Kim YH..  (2014)  Anti-inflammatory components of Euphorbia humifusa Willd.,  24  (8): [PMID:24679441] [10.1016/j.bmcl.2014.03.014]
5. Kato K, Ninomiya M, Tanaka K, Koketsu M..  (2016)  Effects of Functional Groups and Sugar Composition of Quercetin Derivatives on Their Radical Scavenging Properties.,  79  (7): [PMID:27314621] [10.1021/acs.jnatprod.6b00274]

Source